Farid Ramy (CIK 1797707) reported 12 SEC Form 4 insider transactions across 2 companies over the past 18 months (most recent 2026-04-17). Recent activity: Buy SDGR (43,000 shares), Sell SDGR (43,000 shares), Buy SDGR (43,000 shares), Sell SDGR (43,000 shares), Buy SDGR (74,527 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-04-17 | Schrodinger, Inc. (SDGR) | President & CEO | Buy | 43,000 | $132,010 |
| 2026-04-17 | Schrodinger, Inc. (SDGR) | President & CEO | Sell | 43,000 | $530,233 |
| 2026-04-17 | Schrodinger, Inc. (SDGR) | President & CEO | Buy | 43,000 | $132,010 |
| 2026-04-17 | Schrodinger, Inc. (SDGR) | President & CEO | Sell | 43,000 | $524,944 |
| 2026-04-17 | Schrodinger, Inc. (SDGR) | President & CEO | Buy | 74,527 | $228,798 |
| 2026-03-06 | Schrodinger, Inc. (SDGR) | President & CEO | Sell | 3,661 | $47,264 |
| 2026-03-03 | Schrodinger, Inc. (SDGR) | President & CEO | Buy | 56,250 | $0 |
| 2026-03-03 | Schrodinger, Inc. (SDGR) | President & CEO | Buy | 13,604 | $0 |
| 2026-03-03 | Schrodinger, Inc. (SDGR) | President & CEO | Buy | 48,259 | $0 |
| 2026-03-03 | Schrodinger, Inc. (SDGR) | President & CEO | Sell | 5,560 | $66,164 |
| 2025-06-02 | Vir Biotechnology, Inc. (VIR) | Director | Buy | 8,000 | $0 |
| 2025-03-04 | Schrodinger, Inc. (SDGR) | President & CEO | Buy | 37,500 | $0 |
Source: SEC Form 4 filings · as of 2026-04-17